Cells containing Epstein-Barr nuclear antigen (EBNA) in peripheral blood

L. Gergely, J. Czegledy, L. Vaczi, A. Szalka, E. Berényi

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The anti-complement immunofluorescence method was used to demonstrate EBNA in B lymphocytes separated from the peripheral blood of patients with infectious mononucleosis (IM) or other diseases. In the acute phase of IM of Epstein-Barr virus (EBV) origin, 0.5-1% of the B lymphocytes proved to be positive in 6 of the 8 patients tested. In 2 of the positive cases the test was repeated 20 and 26 days, respectively, after clinical symptoms had appeared; the result was negative in both cases. No EBNA-positive cells were found in the peripheral blood of 17 patients with Hodgkin's disease, 3 with systemic lupus erythematosus and 2 with lymphosarcoma. It is supposed that EBNA-positive cells appear in detectable amounts exclusively in the acute phase of EBV infection.

Original languageEnglish
Pages (from-to)41-45
Number of pages5
JournalActa Microbiologica Academiae Scientiarum Hungaricae
Volume26
Issue number1
Publication statusPublished - 1979

Fingerprint

Nuclear Antigens
Infectious Mononucleosis
B-Lymphocytes
Epstein-Barr Virus Infections
Human Herpesvirus 4
Hodgkin Disease
Systemic Lupus Erythematosus
Non-Hodgkin's Lymphoma
Fluorescent Antibody Technique

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Cells containing Epstein-Barr nuclear antigen (EBNA) in peripheral blood. / Gergely, L.; Czegledy, J.; Vaczi, L.; Szalka, A.; Berényi, E.

In: Acta Microbiologica Academiae Scientiarum Hungaricae, Vol. 26, No. 1, 1979, p. 41-45.

Research output: Contribution to journalArticle

Gergely, L. ; Czegledy, J. ; Vaczi, L. ; Szalka, A. ; Berényi, E. / Cells containing Epstein-Barr nuclear antigen (EBNA) in peripheral blood. In: Acta Microbiologica Academiae Scientiarum Hungaricae. 1979 ; Vol. 26, No. 1. pp. 41-45.
@article{b392b533b44c4c21b752bedfcee2254c,
title = "Cells containing Epstein-Barr nuclear antigen (EBNA) in peripheral blood",
abstract = "The anti-complement immunofluorescence method was used to demonstrate EBNA in B lymphocytes separated from the peripheral blood of patients with infectious mononucleosis (IM) or other diseases. In the acute phase of IM of Epstein-Barr virus (EBV) origin, 0.5-1{\%} of the B lymphocytes proved to be positive in 6 of the 8 patients tested. In 2 of the positive cases the test was repeated 20 and 26 days, respectively, after clinical symptoms had appeared; the result was negative in both cases. No EBNA-positive cells were found in the peripheral blood of 17 patients with Hodgkin's disease, 3 with systemic lupus erythematosus and 2 with lymphosarcoma. It is supposed that EBNA-positive cells appear in detectable amounts exclusively in the acute phase of EBV infection.",
author = "L. Gergely and J. Czegledy and L. Vaczi and A. Szalka and E. Ber{\'e}nyi",
year = "1979",
language = "English",
volume = "26",
pages = "41--45",
journal = "Acta Microbiologica et Immunologica Hungarica",
issn = "1217-8950",
publisher = "Akademiai Kiado",
number = "1",

}

TY - JOUR

T1 - Cells containing Epstein-Barr nuclear antigen (EBNA) in peripheral blood

AU - Gergely, L.

AU - Czegledy, J.

AU - Vaczi, L.

AU - Szalka, A.

AU - Berényi, E.

PY - 1979

Y1 - 1979

N2 - The anti-complement immunofluorescence method was used to demonstrate EBNA in B lymphocytes separated from the peripheral blood of patients with infectious mononucleosis (IM) or other diseases. In the acute phase of IM of Epstein-Barr virus (EBV) origin, 0.5-1% of the B lymphocytes proved to be positive in 6 of the 8 patients tested. In 2 of the positive cases the test was repeated 20 and 26 days, respectively, after clinical symptoms had appeared; the result was negative in both cases. No EBNA-positive cells were found in the peripheral blood of 17 patients with Hodgkin's disease, 3 with systemic lupus erythematosus and 2 with lymphosarcoma. It is supposed that EBNA-positive cells appear in detectable amounts exclusively in the acute phase of EBV infection.

AB - The anti-complement immunofluorescence method was used to demonstrate EBNA in B lymphocytes separated from the peripheral blood of patients with infectious mononucleosis (IM) or other diseases. In the acute phase of IM of Epstein-Barr virus (EBV) origin, 0.5-1% of the B lymphocytes proved to be positive in 6 of the 8 patients tested. In 2 of the positive cases the test was repeated 20 and 26 days, respectively, after clinical symptoms had appeared; the result was negative in both cases. No EBNA-positive cells were found in the peripheral blood of 17 patients with Hodgkin's disease, 3 with systemic lupus erythematosus and 2 with lymphosarcoma. It is supposed that EBNA-positive cells appear in detectable amounts exclusively in the acute phase of EBV infection.

UR - http://www.scopus.com/inward/record.url?scp=0018342059&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018342059&partnerID=8YFLogxK

M3 - Article

C2 - 225932

AN - SCOPUS:0018342059

VL - 26

SP - 41

EP - 45

JO - Acta Microbiologica et Immunologica Hungarica

JF - Acta Microbiologica et Immunologica Hungarica

SN - 1217-8950

IS - 1

ER -